Recon: FDA warns Applied Therapeutics over clinical trial handling; Roivant to halt sarcoidosis drug development
ReconJason Scott
Biologics/ biosimilars/ vaccinesEnforcementEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)Warning letters